Pulse Biosciences Inc (PLSE)
NASDAQ
Closed
Oct 8, 2026
Day's Range
47.3152 wk Range
12.56Profile - PLSE - Pulse Biosciences Inc
Profile
Mic Code
XNCM
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
116
Pulse Biosciences Inc is a bioelectric medicine company focused on developing and commercializing medical technologies that use proprietary pulsed-field energy to treat targeted cells while preserving surrounding tissue. Its current product portfolio includes the nPulse System for benign skin lesions, the nPulse Vybrance Percutaneous Electrode system for soft tissue ablation, the nPulse Cardiac Surgical Clamp for atrial fibrillation procedures, the nPulse Cardiac Catheter System for circumferential cardiac ablation, and the nPulse Console, a software-enabled platform designed to support physician workflows. The company serves healthcare providers across dermatology, surgical soft-tissue care, and cardiac electrophysiology, with applications centered on minimally invasive treatment approaches. Pulse Biosciences Inc positions itself within the medical device market through its proprietary energy-based platform, which is designed for clinical use in areas where precise cellular targeting is important.
Profile Details
Type
Common Stock
Address
601 Brickell Key Drive
City
Miami
State
FL
Zip
33131
Country
United States
Phone
510 906 4600
Key Executives - PLSE - Pulse Biosciences Inc
Key executives
Cross Listings - PLSE - Pulse Biosciences Inc
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
